NCBiotech News

Wake Forest School of Medicine continues its Exploring Ethics 2018-2019 series “Taboo Topics: Evidence-based Strategies for Navigating Tough Conversations in Pediatric Oncology Care” this Thursday, April 4, from noon to 1:15 p.m. in Winston-Salem.

Raleigh-based Applied LifeSciences & Systems (ALSS) closed an $8 million Series A equity financing this month to accelerate development of its innovative technologies for individually vaccinating chickens at their time of hatching to reduce the need for antibiotics later.

Humacyte, a regenerative medicine company based in Durham, has demonstrated that its human acellular vessels (HAVs) repopulate with a patient’s own cells to form a living vascular tissue.

Early buyers were willing to pay a premium today to own a piece of Durham-based Precision BioSciences.

Innovate Biopharmaceuticals, a Raleigh clinical-stage biotechnology company, will partner with a French oncology researcher to find out if gut microbes influence the effectiveness of certain cancer treatments.

The next WE Pitch “Shark Tank”-type event, to help take business development for women entrepreneurs in Central North Carolina to the next level, is scheduled for 6:30 p.m. June 20 at the Carolina Theater in Durham, presented by Central Carolina Women in Business.

Mayne Pharma, a developer and manufacturer of pharmaceuticals, which opened a new $80 million Greenville facility in 2018, is launching the Mayne Scholarship program at Pitt Community College (PCC) this fall.

An article just published on BioSpace.com, a life science industry news and information source, hails North Carolina as a life science “Hotbed,” praising the Research Triangle region’s “whopping” life science growth this century of 108 percent. “The region benefits from an abundance of life sciences talent and a disproportionate amount of NIH funding compared to other regions,” it says

Durham-based Bioventus, which develops orthobiologic products, is launching OSTEOAMP SELECT Fibers, an innovative addition to its allograft line of bone graft substitutes for spine, foot & ankle, orthopaedic, and trauma surgeons.

When you get an injection, apply eye drops, swallow cough syrup or apply mascara, there’s a good chance that the product may have been packaged by a machine made by groninger, a German company with a growing U.S. headquarters in Charlotte.

KNOW Bio, LLC, a Durham life science incubator, is merging its gut instinct with the scientific method by pursuing a belief that its nitric oxide-based platform has therapeutic applications for conditions of the gastrointestinal tract.

The Economic Development Partnership of North Carolina (EDPNC) is once again registering North Carolina manufacturers for its annual Go Global Road Show, which is being presented April 1-4 in four locations across the state.

Seafood innovators from around the world will converge in North Carolina’s coastal business and recreational magnet of Wilmington April 23 and 24 for the second two-day Fish 2.0, workshop.

bluebird bio, a Massachusetts-based gene and cell therapy company, has opened its first wholly owned manufacturing facility in Durham amid cheers from state leaders.

Lenoir is a small town in the rural foothills, away from the state’s renowned technology hubs. But it's home to Exela Pharma Sciences, a fast-growing manufacturer of generic sterile injectable medications backed by venture capital, government grants and loans, investments by family and friends and personal funds of founder Phanesh Koneru. In its first decade it has grown to 320 employees, and it’s hiring more.